Literature DB >> 27319292

Harnessing gene and drug delivery for vascularizing engineered tissue platforms.

Gabrielle C Lam1, Michael V Sefton2.   

Abstract

Enhancement of tissue vascularization is a therapeutic target for many ischemic conditions, and is crucial for successful engraftment of therapeutic cells for tissue regeneration. The authors present opportunities for using these platforms for dissecting the role of angiogenic mechanisms and highlight recent gene and drug delivery strategies for enhancing vascularization of engineered tissues. Modular tissue engineering is featured as an example.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27319292     DOI: 10.1016/j.drudis.2016.06.002

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  2 in total

Review 1.  Endothelial Progenitor Cells for the Vascularization of Engineered Tissues.

Authors:  Erica B Peters
Journal:  Tissue Eng Part B Rev       Date:  2017-07-03       Impact factor: 6.389

2.  Construction of Pedicled Smooth Muscle Tissues by Combining the Capsule Tissue and Cell Sheet Engineering.

Authors:  Zhiming Jia; Hailin Guo; Hua Xie; Junmei Zhou; Yaping Wang; Xingqi Bao; Yichen Huang; Fang Chen
Journal:  Cell Transplant       Date:  2019-01-09       Impact factor: 4.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.